Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: Functional cardiorenal responses to receptor antagonism

Clinical Science

Volumn 95, Issue 2, 1998, Pages 195-202

  Borgeson, Daniel D ^a   Stevens, Tracy L ^a   Heublein, Denise M ^a   Matsuda, Yuzuru ^a   Burnett, John C ^a  

^a MAYO CLINIC   (United States)

Author keywords

Natriuresis; Natriuretic peptides; Volume expansion

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CELL RECEPTOR; NATRIURETIC FACTOR; NATRIURETIC PEPTIDE RECEPTOR; NATRIURETIC PEPTIDE TYPE C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; BODY WEIGHT; CONTROLLED STUDY; DIURESIS; ENDOTHELIUM CELL; HEART ATRIUM PRESSURE; HEART MUSCLE CELL; HEART OUTPUT; HEART RIGHT ATRIUM PRESSURE; KIDNEY EPITHELIUM; LUNG ARTERY PRESSURE; LUNG CAPILLARY PRESSURE; MALE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; URINE LEVEL;

EID: 0031663657     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0950195     Document Type: Article

References (40)

1. Brenner, B. M., Ballerman, B. J., Gunning, M. E. and Zeidel, M. L. (1990) Diverse biological actions of atrial natriuretic peptide. Physiol. Rev. 70, 665-687
2. Burnett, Jr, J. C., Granger, J. P. and Opgenorth, T. J. (1984) Effects of synthetic atrial natriuretic factor on renal function and renin release. Am. J. Physiol. 247, F863-F868
3. DeBold, A. J, Borenstein, H. B., Veress, A. T. and Sonnenberg, H. (1986) A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci. 28, 88-94
4. Maack, T. M., Camargo, M. J. F., Kleinfert, H. D., Laragh, J. H. and Atlas, S. A. (1985) Atrial natriuretic factor: structure and functional properties. Kidney Int. 27, 607-615
5. Mattingly, M. T., Brandt, R. R., Heublein, D. M., Wei, C. M., Nir, A. and Burnett, Jr, J. C. (1994) Presence of C-type natriuretic peptide in human kidney and urine. Kidney Int. 46, 744-747
6. Stingo, A. J., Clavell, A. L., Heublein, D. M., Wei, C. M., Pitttelkow, M. R. and Burnett, Jr, J. C. (1992) Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. Am. J. Physiol. 263, H1318-H1321
7. Koller, K. J. and Goeddel, D. V. (1992) Molecular biology of the natriuretic peptides and their receptors. Circulation 86, 1081-1088
8. Zimmerman, R. S., Edwards, B. S., Schwab, T. R., Heublein, D. M. and Burnett, Jr, J. C. (1987) Cardiorenal-endocrine dynamics during and following volume expansion. Am. J. Physiol. R336-R340
9. Hirth, C., Stasch, J. P., Kazada, J. S., Morich, F., Neuser, D. and Wohlfeil, S. (1986) The renal response to acute hypervolemia is caused by atrial natriuretic peptides. J. Cardiovasc. Pharmacol. 8, 268-275
10. Edwards, B. S., Zimmerman, R. S., Schwab, T. R., Heublein, D. M. and Burnett, Jr, J. C. (1988) Atrial stretch, not pressure is the principle determinant controlling the acute release of atrial natriuretic factor. Clin. Res. 62, 191-195
11. Stevens, T. L., Burnett, Jr, J. C., Kinoshita, M., Matsuda, Y. and Redfield, M. M. (1995) A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction. J. Clin. Invest. 95, 1101-1108
12. Zhang, P. L., Jimenez, W., Mackenzie, H. S., et al. (1994) HS-142-1, a potent antagonist of natriuretic peptides in vitro and in vivo. J. Soc. Nephrol. 5, 1099-1105
13. Zhang, P. L., Mackenzie, H. S., Troy, J. L. and Brenner, B. M. (1994) Effects of natriuretic peptide receptor antagonist on remnant kidney function in rats. Kidney Int. 46, 414-420
14. Kishimito, I., Dubois, S. K. and Garbers, D. L. (1996) The heart communicates with the kidney exclusively through the guanylyl cyclase-A receptor: acute handling of sodium and water in response to volume expansion. Proc. Natl. Acad. Sci. USA 93, 6215-6219
15. Lang, C. C., Choy, A. M. J., Turner, K., Tobin, R., Coutie, W. and Struthers, A. D. (1993) The effect of intravenous saline loading on plasma levels of brain natriuretic peptide in man. J. Hypertens. 11, 737-741
16. Wambach, G. and Koch, J. (1995) BNP plasma levels during acute volume expansion and chronic sodium loading in normal men. Clin. Exp. Hypertens. 17, 619-629
17. Nakagawa, O., Ogawa, Y., Itoh, H., et al. (1995) Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an 'emergency' cardiac hormone against ventricular overload. J. Clin. Invest. 96, 1280-1287
18. Suga, S., Nakao, K., Hodada, K., et al. (1992) Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology (Baltimore) 130, 229-239
19. Totsune, K., Takahashi, K., Murakami, O., et al. (1994) Natriuretic peptides in the human kidney. Hypertension 24, 758-762
20. Imura, R., Sano, T., Goto, J., Yamada, K. and Matsuda, Y. (1992) Inhibition by HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin, of atrial natriuretic peptide induced relaxation of isolated rabbit aorta through the blockade of guanylyl cyclase-linked receptors. Mol. Pharmacol. 42, 982-990
21. Matsuda, Y. and Morishita, Y. (1993) HS-142-1: A novel nonpeptide atrial natriuretic peptide antagonist of microbial origin. Cardiovasc. Drug Rev. 11, 45-49
22. Morishita, Y., Sano, T., Ando, K., et al. (1991) Microbial polysaccharide, HS-142-1, competitively and selectively inhibits ANP binding to its guanylyl cyclase containing receptor. Biochem. Biophys. Res. Commun. 176, 949-957
23. Sano, T., Morishita, Y., Matsuda, Y. and Yamada, K. (1992) Pharmacologic profile of HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin. Selective inhibition of the actions of natriuretic peptides in anesthetized rats. J. Pharmacol. Exp. Ther. 260, 825-831
24. Stevens, T. L., Wei, C. M., Aarhus, L. L., et al. (1994) Modulation of exogenous and endogenous atrial natriuretic peptide by a receptor antagonist. Hypertension 23, 613-618
25. Burnett, Jr, J. C., Kao, P. C., Hu, D. C., et al. (1986) Atrial natriuretic peptide elevation in congestive heart failure in the human. Science (Washington DC) 231, 1145-1147
26. Gutkowska, J., Horky, K., Lachance, C., et al. Atrial natriuretic factor in spontaneously hypertensive rats. Hypertension (1986) 8, 1137-1140
27. Steiner, A. L., Parker, C. W. and Kipnis, D. M. (1972) Radioimmunoassay for cyclic nucleotidase. J. Biol. Chem. 247, 1106-1113
28. Fuhr, J., Kaczmarczyk, K. J. and Kurtgen, C. D. (1955) Eine einfache colormetrische methode zur inulinbestimmung fur nierenclearance-undersuchungen bei-stoffwechelsgesuden and diabetikern. Klin. Wochenschr. 33, 729-730
29. Thomsen, K., Holstein-Rathow, N. H. and Leyssac, P. P. (1981) Comparison of three measures of proximal tubular reabsorption: lithium clearance, occlusion time, and micropuncture. Am. J. Physiol. 241, F348-F355
30. Hayslett, J. P. and Kashgarian, M. (1979) A micropuncture study of the renal handling of lithium. Pflugers Arch. 380, 159-163
31. Burnett, Jr, J. C., Osborn, M. J., Hammill, S. C. and Heublein, D. M. (1989) The role of frequency of atrial contraction versus pressure in atrial natriuretic peptide release. J. Clin. Endocrinol. Metab. 69, 881-884
32. LaPointe, M. C. and Sitkins, J. R. (1993) Phorbol ester stimulates the synthesis and secretion of brain natriuretic peptide from neonatal rat ventricular cardiocytes: a comparison with the regulation of atrial natriuretic factor. Mol. Endocrinol. 7, 1284-1296
33. Wei, C. M., Heublein, D. M., Perella, M. A., et al. (1993) Natriuretic peptides in human heart failure. Circulation 88, 1004-1009
34. Matsuda, Z. (1997) Design and utilization of natriuretic peptide antagonists. In Contemporary Endocrinology: Natriuretic Peptides in Health and Disease, N4 (Samson, W. K. and Levin, E. R., eds.), pp. 289-308, Humana Press Inc., Totowa, NJ
35. Zhang, P. L., Mackenzie, H. S., Totsune, K., Troy, J. L. and Brenner, B. M. (1995) Renal effects of high-dose natriuretic peptide receptor blockade in rats with congestive heart failure. Circ. Res. 77, 1240-1245
36. Wei, C. M., Aarhus, L. L., Miller, V. M. and Burnett, Jr, J. C. (1993) The action of C-type natriuretic peptide in isolated canine arteries and veins. Am. J. Physiol. 264, H71-H73
37. Wei, C. M., Kim, C. H., Miller, V. M. and Burnett, Jr, J. C. (1993) Vasonatrin peptide: a unique synthetic natriuretic and vasorelaxing peptide. J. Clin. Invest. 93, 2048-2052
38. Fraenkel, M. B., Aldred, G. P. and McDougal, J. G. (1994) Sodium status affects GC-B natriuretic peptide receptor mRNA levels, but not GC-A or C receptor mRNA levels, in the sheep kidney. Clin. Sci. 86, 517-522
39. Davidson, N. C., Barr, C. S. and Struthers, A. D. (1996) C-type natriuretic peptide. An endogenous inhibitor of vascular angiotensin-converting enzyme activity. Circulation 93, 1155-1159
40. Knox, F., Mertz, J. I., Burnett, Jr, J. C. and Haramati, A. (1983) Role of hydrostatic and oncotic pressures in renal sodium reabsorption. Circ. Res. 52, 491-500